Targeting the IL-17 Pathway in Inflammatory Disorders

Cong-Qiu Chu

Springer International Publishing

1

2017

en

9783319280400

iLEIO | PCs Apple App Store Android no Google Play

This book provides an overview of the discovery and structure of IL-17, including its pathogenesis and role in chronic inflammation and autoimmunity. To capture the latest developments and product approvals the book also discusses the therapeutic advances and looks at emerging therapies targeting the IL-17 pathway. IL-17 is a pro-inflammatory cytokine that has a key role in inflammation, autoimmunity, and host defense in a number of inflammatory disorders such as rheumatoid arthritis, psoriatic arthritis and psoriasis, ankylosing spondylitis, multiple sclerosis, and inflammatory bowel disease. The discovery of the IL-17-Th17 pathway has seen exciting development in the field of immunology and inflammation research, which has led to a number of recent regulatory approvals.
Índice não disponível.
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado. Saúde pública e medicina preventiva
Prática geral
Dermatologia
Reumatologia
Farmacologia
Licença Impressão
Acesso Perpétuo 11 paginas a cada 30 dias

Leitura online: um utilizador por sessão (sem simultaneidade)
Leitura offline (com a APP): máximo de 2 dispositivos em simultâneo